Concomitant chronic lymphocytic leukemia and acute myeloid leukemia: Evidence of simultaneous expansion of two independent clones

References

• Hisada M, Biggar R J, Greene M H, Fraumeni J F, Jr, Travis L B. Solid tumors after chronic lymphocytic leukemia. Blood 2001; 15(98)1979–1981
   Web of Science ®Google Scholar
• Travis L B, Curtis R E, Hankey B F, Fraumeni J F, Jr. Second cancers in patients with chronic lymphocytic leukemia. J Natl Cancer Inst 1992; 16: 1422–1427
   Web of Science ®Google Scholar
• Greene M H, Hoover R N, Fraumeni J F, Jr. Subsequent cancer in patients with chronic lymphocytic leukemia–a possible immunologic mechanism. J Natl Cancer Inst 1978; 61: 337–340
   PubMed Web of Science ®Google Scholar
• Lai R, Arber D A, Brynes R K, Chan O, Chang K L. Untreated chronic lymphocytic leukemia concurrent with or followed by acute myelogenous leukemia or myelodysplastic syndrome. A report of five cases and review of the literature. Am J Clin Pathol 1999; 111: 373–378
   PubMed Web of Science ®Google Scholar
• Gattei V, Degan M, Gloghini A, De Iuliis A, Improta S, Rossi F M, et al. CD30 ligand is frequently expressed in human hematopoietic malignancies of myeloid and lymphoid origin. Blood 1997; 89: 2048–2059
   PubMed Web of Science ®Google Scholar
• Degan M, Mazzocco F T, Di Francia R, Rossi F M, Pinto A, Gattei V. Normalizing complementary DNA by quantitative reverse transcriptase-polymerase chain reaction of beta2-microglobulin: molecular monitoring of minimal residual disease in acute promyelocytic leukemia. Diagn Mol Pathol 2000; 9: 98–109
   PubMed Web of Science ®Google Scholar
• van Dongen J J, Macintyre E A, Gabert J A, Delabesse E, Rossi V, Saglio G, et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia 1999; 13: 1901–1928
   PubMed Web of Science ®Google Scholar
• Fais F, Ghiotto F, Hashimoto S, Sellars B, Valetto A, Allen S L, et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest 1998; 15: 1515–1525
   Web of Science ®Google Scholar
• Krober A, Seiler T, Benner A, Bullinger L, Bruckle E, Lichter P, et al. V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood 2002; 100: 1410–1416
   PubMed Web of Science ®Google Scholar
• Degan M, Bomben R, Bo M D, Zucchetto A, Nanni P, Rupolo M, et al. Analysis of IgV gene mutations in B cell chronic lymphocytic leukaemia according to antigen-driven selection identifies subgroups with different prognosis and usage of the canonical somatic hypermutation machinery. Br J Haematol 2004; 126: 29–42
   PubMed Web of Science ®Google Scholar
• Ranheim E A, Jones C D, Zehnder J L. Sensitive detection of clonal immunoglobulin rearrangements in frozen and paraffin embedded tissues by polymerase chain reaction heteroduplex analysis. Diagn Mol Pathol 2000; 9: 177–183
   PubMed Web of Science ®Google Scholar
• Damle R N, Wasil T, Fais F, Ghiotto F, Valetto A, Allen S L, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999; 94: 1840–1847
   PubMed Web of Science ®Google Scholar
• Robertson L E, Estey E, Kantarjian H, Koller C, O'Brien S, Brown B, Keating M J. Therapy-related leukemia and myelodysplastic syndrome in chronic lymphocytic leukemia. Leukemia 1994; 8: 2047–2051
   PubMed Web of Science ®Google Scholar
• Rund D, Ben-Yehuda D. Therapy-related leukemia and myelodysplasia: evolving concepts of pathogenesis and treatment. Hematology 2004; 9: 179–187
   PubMedGoogle Scholar
• Rosenthal N S, Farhi D C. Reactive plasmacytosis and lymphocytosis in acute myeloid leukemia. Hematol Pathol 1994; 8: 43–51
   PubMedGoogle Scholar
• Graf T. Differentiation plasticity of hematopoietic cells. Blood 2002; 99: 3089–3101
   PubMed Web of Science ®Google Scholar
• Hou Y H, Srour E F, Ramsey H, Dahl R, Broxmeyer H E, Hromas R. Identification of a human B-cell/myeloid common progenitor by the absence of CXCR4. Blood 2005; 13, Epub ahead of print
   Google Scholar
• Esteve J, Cervantes F, Rives S, Rozman M, Zarco M A, Montserrat E. Simultaneous occurrence of B-cell chronic lymphocytic leukemia and chronic myeloid leukemia with further evolution to lymphoid blast crisis. Haematologica 1997; 82: 596–599
   PubMed Web of Science ®Google Scholar
• Mitterbauer G, Schwarzmeier J, Mitterbauer M, Jaeger U, Fritsch G, Schwarzinger I. Myelodisplastic syndrome/acute myeloid leukemia superventing previously untreated chronic B-lymphocytic leukemia: demonstration of the concomitant presence of two different malignant clones by immunologic and molecular analysis. Ann Hematol 1997; 74: 193–197
   PubMed Web of Science ®Google Scholar
• Davi F, Faili A, Gritti C, Blanc C, Laurent C, Sutton L, et al. Early onset of immunoglobulin heavy chain gene rearrangements in normal human bone marrow CD34 + cells. Blood 1997; 15: 4014–4021
   Google Scholar
• Kyoda K, Nakamura S, Matano S, Ohtake S, Matsuda T. Prognostic significance of immunoglobulin heavy chain gene rearrangement in patients with acute myelogenous leukemia. Leukemia 1997; 11: 803–806
   PubMed Web of Science ®Google Scholar
• Montefusco E, Fazi F, Cordone I, Ariola C, Nanni M, Spadea A, et al. Molecular remission following high-dose hydroxyurea and fludarabine plus cytarabine in a patient with simultaneous acute myeloid leukemia and low-grade lymphoma. Leuk Lymphoma 2001; 40: 671–674
   PubMed Web of Science ®Google Scholar